Literature DB >> 2844841

Separation of proteins by reversed-phase high-performance liquid chromatography. I. Optimizing the column.

W G Burton1, K D Nugent, T K Slattery, B R Summers, L R Snyder.   

Abstract

In the process of developing a new analytical technology (the chromatophoresis process) which couples reversed-phase high-performance liquid chromatography (HPLC) to sodium dodecyl sulfate polyacrylamide gel electrophoresis in a real-time automated system, it was apparent that improvements in resolving power for the first-dimension (HPLC) separation were necessary. The present paper describes the optimization of the column for our initial work on reversed-phase HPLC separations. Polymeric (polystyrene) packings having particle diameters of 5 micron and pore diameters of 300 A were generally superior in terms of resolution, sample recovery and minimization of "ghosting". Optimum column dimensions were 50 x 1.0 mm I.D. for the flow-rates required in our system (10-100 microliter/min).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844841     DOI: 10.1016/s0021-9673(00)94808-8

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

1.  Grafted block complex coacervate core micelles and their effect on protein adsorption on silica and polystyrene.

Authors:  Agata M Brzozowska; Arie de Keizer; Willem Norde; Christophe Detrembleur; Martien A Cohen Stuart
Journal:  Colloid Polym Sci       Date:  2010-05-13       Impact factor: 1.931

Review 2.  Endocrine role of bone in the regulation of energy metabolism.

Authors:  Ruoyu Zhou; Qiaoyue Guo; Ye Xiao; Qi Guo; Yan Huang; Changjun Li; Xianghang Luo
Journal:  Bone Res       Date:  2021-05-20       Impact factor: 13.567

3.  A sensitive multidimensional method for the detection, characterization, and quantification of trace free drug species in antibody-drug conjugate samples using mass spectral detection.

Authors:  Robert E Birdsall; Sean M McCarthy; Marie Claire Janin-Bussat; Michel Perez; Jean-François Haeuw; Weibin Chen; Alain Beck
Journal:  MAbs       Date:  2015-12-14       Impact factor: 5.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.